[An indirect hemagglutination study of total IgE and complement fractions C3c and C4 in patients with hepatic hydatidosis and undergoing therapy].
The trend of antibodies tested with indirect hemagglutination, of total IgE and complement fraction was examined in patients with liver hydatid disease, treated with surgery and benzoimidazoles.
Orlando
R
R
II Facoltà di Medicina e Chirurgia, Università degli Studi di Napoli.
Tosone
G
G
Del Pezzo
M
M
Piccoli
S
S
Rendano
F
F
Palimento
D
D
Conti
A
A
D000328:Adult; D015766:Albendazole / Q000627:therapeutic use; D003131:Combined Modality Therapy; D015932:Complement C3c / Q000032:analysis*; D003181:Complement C4 / Q000032:analysis*; D004444:Echinococcosis, Hepatic / Q000188:drug therapy / Q000276:immunology* / Q000601:surgery; D005260:Female; D006386:Hemagglutination Tests; D006801:Humans; D007073:Immunoglobulin E / Q000032:analysis*; D008099:Liver / Q000601:surgery; D008297:Male; D008463:Mebendazole / Q000627:therapeutic use; D011182:Postoperative Care; D011300:Preoperative Care
D003181:Complement C4; D007073:Immunoglobulin E; D015932:Complement C3c; D008463:Mebendazole; D015766:Albendazole
Studio dell'emoagglutinazione indiretta, delle IgE totali e delle frazioni del complemento C3c e C4 in pazienti affetti da idatidosi epatica e sottoposti a terapia.